Last reviewed · How we verify

NCT03539562

Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep

Completed Last updated 29 July 2020
What this trial tests

trial testing Morphine Sulfate and Promethazine in Labor Pain in 82 participants. Completed in 1 April 2020.

Timeline
27 September 2017
Primary endpoint
1 April 2020
1 April 2020

Quick facts

Lead sponsorUniversity of California, San Francisco
StatusCompleted
Study typeOBSERVATIONAL
Enrollment82
Start date27 September 2017
Primary completion1 April 2020
Estimated completion1 April 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

Adults 18 to 55, female only, with Labor Pain or Early Labor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This will be a prospective study on labor characteristics, and obstetric and neonatal outcomes in women who accept and women who decline morphine as a form of pain management in labor. The study will also investigate patient satisfaction with this form of analgesia. The participants will be those who accept morphine and promethazine and those who decline morphine and promethazine for pain control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Labor Pain

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03539562.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing